Study Summary
A Clinical Study on the Safety and Effectiveness of donor derived CD19 CAR-T Cells in the treatment of R/R B-cell acute lymphoblastic leukemia
Interested in this trial?
Submit an InquiryInterventions
CD19 B-cell Acute Lymphoblastic Leukemia Targeted CAR T-cells injectionBIOLOGICAL
Each subject receive CD19 B-cell Acute Lymphoblastic Leukemia Targeted CAR T-cells by intravenous infusion
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| The first affiliated hospital of medical college of zhejiang university | Hangzhou | Zhejiang | China |